MX2012013395A - Matriz sintetica absorbible reforzada para aplicaciones hemostaticas. - Google Patents

Matriz sintetica absorbible reforzada para aplicaciones hemostaticas.

Info

Publication number
MX2012013395A
MX2012013395A MX2012013395A MX2012013395A MX2012013395A MX 2012013395 A MX2012013395 A MX 2012013395A MX 2012013395 A MX2012013395 A MX 2012013395A MX 2012013395 A MX2012013395 A MX 2012013395A MX 2012013395 A MX2012013395 A MX 2012013395A
Authority
MX
Mexico
Prior art keywords
reinforced absorbable
synthetic matrix
absorbable synthetic
hemostatic applications
hemostatic
Prior art date
Application number
MX2012013395A
Other languages
English (en)
Inventor
Robert W Van Holten
Olajompo Moloye-Olabisi
Dhanuraj S Shetty
Degang Zhong
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MX2012013395A publication Critical patent/MX2012013395A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se dirige a un hemostático absorbible reforzado que comprende al menos un agente hemostático en una sola capa de una tela sintética no tejida que tiene una mezcla de segmentos de fibras comprimidas de un copolímero de poliglicólido/poliláctido y una polidioxanona.
MX2012013395A 2010-05-17 2011-05-16 Matriz sintetica absorbible reforzada para aplicaciones hemostaticas. MX2012013395A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/781,103 US8273369B2 (en) 2010-05-17 2010-05-17 Reinforced absorbable synthetic matrix for hemostatic applications
PCT/US2011/036590 WO2011146359A1 (en) 2010-05-17 2011-05-16 Reinforced absorbable synthetic matrix for hemostatic applications

Publications (1)

Publication Number Publication Date
MX2012013395A true MX2012013395A (es) 2012-12-10

Family

ID=44911985

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013395A MX2012013395A (es) 2010-05-17 2011-05-16 Matriz sintetica absorbible reforzada para aplicaciones hemostaticas.

Country Status (11)

Country Link
US (2) US8273369B2 (es)
EP (1) EP2571540B1 (es)
JP (1) JP5905451B2 (es)
CN (2) CN102892439A (es)
AU (1) AU2011256403B2 (es)
BR (1) BR112012029293B1 (es)
CA (1) CA2799916C (es)
ES (1) ES2659173T3 (es)
MX (1) MX2012013395A (es)
RU (1) RU2574016C2 (es)
WO (1) WO2011146359A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101703095B1 (ko) 2010-06-17 2017-02-06 워싱톤 유니버시티 정렬된 섬유를 포함하는 생의학용 패치
DK2851085T3 (da) * 2012-05-14 2019-09-09 Teijin Ltd Proteinsammensætning steriliseret ved stråling
EP2851095B1 (en) * 2012-05-14 2021-07-14 Teijin Limited Sheet molding and hemostatic material
AU2015268656B2 (en) * 2012-08-31 2016-11-03 W. L. Gore & Associates, Inc. Reactive oxidative species generating materials and methods of use
US20140065090A1 (en) 2012-08-31 2014-03-06 W. L. Gore & Associates, Inc. Reactive Oxidative Species Generating Materials and Methods of Use
US9259435B2 (en) * 2012-08-31 2016-02-16 W. L. Gore & Associates, Inc. Reactive oxidative species generating materials and methods of use
CA3066269C (en) 2012-09-21 2022-03-29 Washington University Multilayered biomedical structures configured to separate after a predetermined time or upon exposure to an environmental condition
KR101878774B1 (ko) * 2015-04-15 2018-07-17 주식회사 삼양바이오팜 다기능성 지혈제 및 그 제조 방법
US10279086B2 (en) 2015-08-31 2019-05-07 Ethicon Llc Composite adjunct materials for delivering medicants
US10188390B2 (en) 2015-08-31 2019-01-29 Ethicon Llc Adjunct material to provide heterogeneous drug elution
US10194936B2 (en) 2015-08-31 2019-02-05 Ethicon Endo-Surgery, Llc Adjunct material for delivery to stomach tissue
US10569071B2 (en) 2015-08-31 2020-02-25 Ethicon Llc Medicant eluting adjuncts and methods of using medicant eluting adjuncts
US10463366B2 (en) 2015-08-31 2019-11-05 Ethicon Llc Adjunct materials for delivery to liver tissue
US10285692B2 (en) 2015-08-31 2019-05-14 Ethicon Llc Adjuncts for surgical devices including agonists and antagonists
US10172973B2 (en) 2015-08-31 2019-01-08 Ethicon Llc Surgical adjuncts and medicants for promoting lung function
US10086116B2 (en) 2015-08-31 2018-10-02 Ethicon Llc Adjunct material to provide controlled drug release
US10111661B2 (en) 2015-08-31 2018-10-30 Ethicon Llc Matrix metalloproteinase inhibiting adjuncts for surgical devices
US10349938B2 (en) 2015-08-31 2019-07-16 Ethicon Llc Surgical adjuncts with medicants affected by activator materials
US10076329B2 (en) 2015-08-31 2018-09-18 Ethicon Llc Adjunct material to promote tissue growth in a colon
US10245034B2 (en) 2015-08-31 2019-04-02 Ethicon Llc Inducing tissue adhesions using surgical adjuncts and medicants
US10076324B2 (en) 2015-08-31 2018-09-18 Ethicon Llc Adjunct material to provide controlled drug elution
US10213520B2 (en) 2015-08-31 2019-02-26 Ethicon Llc Surgical adjuncts having medicants controllably releasable therefrom
US10130738B2 (en) 2015-08-31 2018-11-20 Ethicon Llc Adjunct material to promote tissue growth
US11020116B2 (en) 2015-08-31 2021-06-01 Ethicon Llc Surgical adjuncts with medicants affected by activators
US9937283B2 (en) 2015-08-31 2018-04-10 Ethicon Endo-Surgery, Llc Adjunct material to provide drug elution from vessels
US10499913B2 (en) 2015-08-31 2019-12-10 Ethicon Llc Tubular surgical constructs including adjunct material
US10188389B2 (en) 2015-08-31 2019-01-29 Ethicon Llc Adjunct material for delivery to colon tissue
CA3004272C (en) 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
EP3426207A1 (fr) * 2016-03-08 2019-01-16 Urgo Recherche Innovation et Développement Pansement se présentant sous la forme d'une bande autoadhérente
BR112018073290B1 (pt) * 2016-05-12 2022-03-03 Acera Surgical, Inc. Material de enxerto não tecido reabsorvível
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
US11254061B2 (en) 2017-01-06 2022-02-22 Ethicon, Inc. Scaffolds for implanting absorbable hemostats in field conditions
US11007299B2 (en) * 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
EP3996759B1 (en) 2019-07-12 2023-08-09 Cilag GmbH International Biocompatible, flexible, haemostatic sheet
US12102722B2 (en) * 2020-06-08 2024-10-01 Ethicon, Inc. Napped coated wound dressing
US11826028B2 (en) * 2020-06-10 2023-11-28 Ethicon, Inc. Two component sealing systems including synthetic matrices and biosynthetic adhesives for sealing resected surfaces of organs to control bleeding, fluid leaks and air leaks
CN117982740B (zh) * 2024-04-07 2024-07-12 四川国纳科技有限公司 可吸收生物医用高分子材料、结扎夹及制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4440789A (en) * 1982-11-16 1984-04-03 Ethicon, Inc. Synthetic absorbable hemostatic composition
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US4741337A (en) * 1985-07-17 1988-05-03 Ethicon, Inc. Surgical fastener made from glycolide-rich polymer blends
CN1035803C (zh) * 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
WO1993017635A1 (en) 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
CA2114282A1 (en) 1993-01-28 1994-07-29 Lothar Schilder Multi-layered implant
US5393594A (en) 1993-10-06 1995-02-28 United States Surgical Corporation Absorbable non-woven fabric
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6733774B2 (en) * 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
AU2004206150B2 (en) * 2003-01-20 2009-10-29 Km Biologics Co., Ltd. Hemostatic materials
RU2005134239A (ru) * 2003-04-04 2006-05-10 Тиссьюмед Лимитед (Gb) Составы тканевых клеев
DK2052746T3 (en) * 2004-10-20 2014-12-08 Ethicon Inc Absorbable hemostatic patch
CN101084022A (zh) * 2004-10-20 2007-12-05 伊西康公司 可吸收的止血物
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
PL2345430T3 (pl) * 2004-10-20 2016-05-31 Ethicon Inc Wzmocniony, absorbowalny, wielowarstwowy materiał do zastosowania w wyrobach medycznych oraz sposób jego wytwarzania
WO2007117237A1 (en) * 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
WO2007117238A1 (en) * 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
AU2007281996B2 (en) 2006-08-04 2013-06-27 Stb, Ltd Solid dressing for treating wounded tissue
US20080095830A1 (en) * 2006-10-20 2008-04-24 Van Holten Robert W Method for making a dressing
US20090004253A1 (en) * 2007-06-29 2009-01-01 Brown Laura J Composite device for the repair or regeneration of tissue
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
US8758447B2 (en) * 2009-06-30 2014-06-24 Ethicon, Inc. Device and method for repair of urological structures

Also Published As

Publication number Publication date
RU2574016C2 (ru) 2016-01-27
EP2571540B1 (en) 2018-01-17
BR112012029293A2 (pt) 2015-09-22
US8273369B2 (en) 2012-09-25
EP2571540A1 (en) 2013-03-27
ES2659173T3 (es) 2018-03-14
WO2011146359A1 (en) 2011-11-24
EP2571540A4 (en) 2013-11-20
CA2799916A1 (en) 2011-11-24
US20120315316A1 (en) 2012-12-13
AU2011256403B2 (en) 2013-10-03
JP2013526368A (ja) 2013-06-24
US8383147B2 (en) 2013-02-26
RU2012154328A (ru) 2014-06-27
CA2799916C (en) 2018-03-13
JP5905451B2 (ja) 2016-04-20
US20110280919A1 (en) 2011-11-17
BR112012029293B1 (pt) 2019-04-24
AU2011256403A1 (en) 2012-12-06
CN106215217A (zh) 2016-12-14
CN102892439A (zh) 2013-01-23

Similar Documents

Publication Publication Date Title
EP2571540A4 (en) REINFORCED ABSORBENT SYNTHETIC MATRIX FOR BLOOD-TREATMENT APPLICATIONS
EP2571466A4 (en) REINFORCED MULTILAYER ABSORBABLE FIBER FOR BLOOD-TREATMENT APPLICATIONS
BR112014013337A2 (pt) dispositivo hemostático bioabsorvível com aglutinante polietilenoglicol
BR112013021127B8 (pt) Dispositivo de implante afastador de válvula nasal bioabsorvível
MX2016005984A (es) Materiales auxiliares híbridos para usarse en engrapado quirúrgico.
MX2012007922A (es) Sellante de fibrina en polvo seco.
BRPI0621537B8 (pt) curativo hemostático de múltiplas camadas absorvível e reforçado para curativo, e método de fabricação
BRPI0516761A (pt) curativo hemostático de múltiplas camadas absorvìvel reforçado e método de produção do mesmo
EP2753371A4 (en) MULTIPLE PULP AND RESORBABLE BONE CEMENTS, HEMOSTATIC COMPOSITIONS, AND METHODS OF USE
BR112012012997A2 (pt) ''microesfera biodegradável, material para utilização em conexão com o tratamento de feridas compreendendo microesferas,curativos de ferida, método para a realização de hemostasia, método para realização do tratamento de uma ferida, método para cultura de células in vitro e método para a realização de embolização vascular"
MX338212B (es) Fibras de dextran electrohiladas y dispositivos formados de las mismas.
WO2012123728A3 (en) Haemostatic material
PL2621357T3 (pl) Chirurgiczne narzędzia do cięcia i zszywania z oddzielnym i oddalonym rozmieszczeniem elementu mocującego i układy tnące tkanki
BR112015008258A2 (pt) artigos multicamadas
CO6541650A2 (es) Esponja hemostática
MX2010003095A (es) Antidotos para inhibidores del factor xa y metodos para usar los mismos.
BR112013030453A2 (pt) núcleo absorvente laminado para uso em artigos absorventes
BR112013009795A2 (pt) instrumento de hemostase e dispositivo cirúrgico para a hemostase de hemorragias
IN2014DN07080A (es)
EP2528529A4 (en) ELECTRODE NEEDLE AND HEMOSTATIC DEVICE COMPRISING SAME
RU2013136405A (ru) Эластичный бинт (варианты)
WO2011138771A3 (en) A combined compression and absorption dressing/bandage
PT2601951E (pt) Composição farmacêutica para o tratamento de hemorragia causada pelo distúrbio da coagulação sanguínea e sua utilização
WO2014091310A3 (en) Hemostatic glove device and method for use of same
BR112013022217A8 (pt) composição farmacêutica, método de tratamento preventivo de uma síndrome hemorrágica em um paciente com hemofilia a ou b e método de tratamento de um acidente hemorrágico em um paciente com hemofilia a ou b

Legal Events

Date Code Title Description
FG Grant or registration